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Abstract
Aims/hypothesis. Moderate alcohol intake has been as-
sociated with increased life expectancy due to reduced
mortality from cardiovascular disease. We prospec-
tively examined the effects of alcohol consumption on
mortality in Type 2 diabetic patients in Switzerland.
Methods. A total of 287 patients with Type 2 diabetes
mellitus (125 women, 162 men), recruited in Switzer-
land for the WHO Multinational Study of Vascular
Disease in Diabetes, were included in this study. After
a follow-up period of 12.6±0.6 years (means ± SD),
mortality from CHD and from all causes was assessed.
Results. During the follow-up, 70 deaths occurred (21
from CHD, 49 from other causes). Compared with
non-drinkers, alcohol consumers who drank alcohol 
1 to 15 g, 16 to 30 g and 30 g or more per day had the
following risk rates of death from CHD: 0.87 (95%
CI: 0.25 to 2.51, NS), 0.00 (95% CI: 0.00 to 0.92,
p less than 0.05) and 0.37 (95% CI, 0.01 to 2.42, NS),
respectively. The corresponding risk rates of death
from all causes were 1.27 (95% CI: 0.68 to 2.28, NS),
0.36 (95% CI: 0.09 to 0.99, p less than 0.05) and 1.66
(95% CI: 0.76 to 3.33, NS).
Conclusions/interpretation. In Swiss Type 2 diabetic
patients moderate alcohol consumption of 16 to 30 g
per day was associated with reduced mortality from
CHD and from all causes. Alcohol intake above 
30 g per day was associated with a tendency towards
increased all-cause mortality. [Diabetologia (2003)
46:1581–1585]
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subjects, and the proportion of diabetic patients includ-
ed in these studies was not known. Recently the pro-
tective effect of light to moderate alcohol consumption
on the risk of cardiovascular morbidity and mortality
in patients with diabetes has been investigated [7, 8, 9,
10]. These studies confirmed the reduced mortality
from CHD in female [8], male [9, 10] and mixed popu-
lations [7] of diabetic patients who drink alcohol, and
are consistent with previous results in people without
diabetes. All of these investigations were carried out in
North America where drinking patterns [11] and type
of alcoholic beverage are possibly different from those
in other areas. Due to differences in the prevalence of
cardiovascular risk factors and differences in ethnicity,
a direct translation of results to other populations
should be treated with caution.
The aim of our study was to find out whether results
obtained in North American populations [7, 8, 9, 10]
Light to moderate alcohol consumption lowers the risk
of CHD and has been associated with increased life ex-
pectancy due to reduced cardiovascular mortality [1, 2,
3, 4, 5]. The benefit of light to moderate alcohol intake
could be highest in people at increased risk of CHD [4,
6]. Most published data demonstrating a cardio-protec-
tive effect of alcohol consumption were obtained in
mixed populations, including primarily non-diabetic
can be repeated in a well-defined, central European
population representative for a whole country. We pro-
spectively examined the relationship between self-re-
ported alcohol consumption and death rates from CHD
and from all causes in Type 2 diabetic patients who
were members of the Swiss cohort of the WHO Multi-
national Study of Vascular Disease in Diabetes [12].
Subjects and methods
Study population. The Swiss cohort [12] of the WHO Multina-
tional Study of Vascular Disease in Diabetes [13, 14] included
533 patients selected randomly, according to the central proto-
col, from the diabetic patients of 231 local practitioners from all
over the country [12]. The sample was representative of a large
area including almost the entire country. Patients were stratified
according to sex, age and duration of diabetes as follows: sex:
255 women, 278 men; age: 35 to 41 years (34.0% women,
32.4% men), 42 to 48 years (34.8% women, 35.3% men), 49 to
55 years (31.3% women, 32.4% men); duration: 1 to 6 years
(34.0% women, 34.5% men), 7 to 13 years (30.1% women,
32.0% men), over 13 years (35.9% women, 33.5% men).
Diabetes mellitus was diagnosed on a clinical basis. Accord-
ing to the central protocol [12, 13], a diabetic patient was de-
fined as someone diagnosed at least 1 year earlier and receiving
specific treatment for diabetes from a physician. All patients
needing insulin treatment within 1 year of diagnosis were de-
fined as having Type 1 diabetes [13]. The remaining patients
were classified as Type 2 diabetic patients. Based on these defi-
nitions, 308 patients were identified as having Type 2 diabetes.
For 287 patients with Type 2 diabetes (93.2%) data on self-
reported alcohol consumption were available. Only these pa-
tients were included in our analysis. Thirteen patients left 
Switzerland and were lost for the final follow-up, but on all of
them intermediary data were available and the day they left the
country was provided by Federal authorities and their physi-
cians. At baseline a standardised clinical examination was done,
including a detailed questionnaire with information on diabetes
diagnosis, duration and treatment, as well as on symptoms of
vascular disease. In addition, height, weight and blood pressure
were recorded. Urine was tested for proteinuria using the
sulphosalicylic acid method. Venous blood was drawn to mea-
sure cholesterol and creatinine. A resting 12-lead electrocardio-
gram was recorded. These baseline investigations were done be-
tween February 1974 and May 1977. Analyses were carried out
in accordance with the Declaration of Helsinki and the Swiss
laws regarding data safety. Data used were made fully anony-
mous before the analyses and only aggregate are reported.
Alcohol consumption. At baseline, the self-reported consump-
tion of alcoholic beverages was assessed and daily alcohol in-
take was calculated on the basis of weekly consumption of
beer, wine and spirits. Depending on daily alcohol intake, four
groups of patients were formed: group 1 with 0 g per day (non-
drinkers); group 2 with 1 to 15 g per day; group 3 with 16 to
30 g per day; and group 4 with more than 30 g per day.
Follow-up and outcome definition. Life or death status was 
ascertained as per January 1st, 1988 after 12.6±0.6 years
(means ± SD, 5543 person-years). During the follow-up 70
deaths were identified. In deceased patients the underlying
cause of death was established from a copy of the death certifi-
cate, hospital records, post-mortem reports (where available)
and from additional information given by the deceased per-
sons’ physicians. The underlying cause of death was coded ac-
cording to the International Classification of Disease 9 (ICD-9)
[15]. CHD included ICD codes 410 to 414.
Statistical analysis. Data analysis was done using Excel (Micro-
soft Corporation, Redmond, Wash., USA), Statview (SAS Insti-
tute, Cary, N.C., USA) and PEPI 4.0 (Computer Programs for
Epidemiologists, Brixton Books, Llanidloes, UK). Data are 
given as means ± SD, as risk rates (RR) with a 95% CI or as in-
cidence rates (rate per 1000 patient-years). Statistical assess-
ment of differences between two or more groups was done us-
ing the two-tailed Student’s t test or ANOVA as appropriate.
Proportions and incidence rates were compared using Fisher’s
exact test. Survival analysis was done using Kaplan-Meier sta-
tistics and the Cox proportional hazards model. The Cox pro-
portional hazards model was used to estimate the relative risk
(and the 95% CI) associated with alcohol consumption and ad-
just it for other risk factors. Patients who left Switzerland were
censored on the day they left the country. A p value of less than
0.05 was considered statistically significant.
Results
Patient characteristics (Table 1). Baseline characteris-
tics of patients who died, patients who survived and
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Table 1. Baseline characteristics of patients studied
Variable All patients Patients who survived Patients who died p values for survivors vs
(n=287) (n=217) (n=70) non-survivors
Age (years) 46.2±5.9 45.5±6.0 48.4±5.2 p<0.001
Sex (male/female) 162/125 116/101 46/24 p=0.096
Duration of diabetes (years) 9.2±6.1 8.8±5.9 10.4±6.4 p=0.053
BMI (kg/m2) 27.6±5.2 27.4±5.3 28.0±4.7 p=0.462
Systolic BP (mmHg) 141±21 138±19 149±24 p<0.001
Diastolic BP (mmHg) 91±12 91±12 93±12 p=0.076
Cholesterol (mmoll) 6.5±1.4 6.6±1.4 6.8±1.4 p=0.094
Triglycerides (mmol/l) 2.4±2.7 2.1±1.9 3.3±4.3 p=0.001
Creatinine (µmol/l) 119±36 107±23 122±60 p=0.003
Glucose (mmol/l) 10.1±4.1 9.8±4.1 10.8±3.9 p=0.079
Nicotine (cigarettes/day) 4±8 4±8 5±9 p=0.192
Alcohol (g per day) 12±28 11±22 16±41 p=0.228
Data are proportions or means ± SD
all patients combined are shown in Table 1. There
were significant differences between patients who
died, patients who survived with respect to age
(p<0.001), systolic blood pressure (p<0.001), triglyce-
rides (p=0.001) and creatinine (p=0.003). P values 
for sex distribution (p=0.096), duration of diabetes
(p=0.053), diastolic blood pressure (p=0.076) and
cholesterol (p=0.094) and fasting plasma glucose
(p=0.079) did not quite reach statistical significance.
Alcohol consumption and mortality (Tables 2 and 3,
Fig. 1). The self-reported consumption of alcoholic
beverages and the calculated average daily alcohol 
intake was documented in all patients. A total of 153
patients (54 men, 99 women) consumed no alcoholic
beverages (group 1, non-drinkers); 61 patients (46
men, 15 women) consumed 1 to 15 g per day (group
2); 42 patients (33 men, 9 women) consumed 16 to
30 g per day (group 3); and 31 patients (29 men, 2
women) consumed more than 30 g per day (group 4).
During a follow-up of 12.6±0.6 years (5543 person-
years) 70 patients (24.4%) died. In 21 patients death
from CHD was documented. In 42 patients consuming
16 to 30 g alcohol per day no deaths from CHD were
registered (for comparison with the non-drinker group
a p value of 0.037 was considered to be significant).
Alcohol consumption above 16 g per day (group 3 and
4 combined) resulted in a significant reduction in mor-
tality from CHD (RR=0.14; 95% CI: 0.02 to 1.04;
p=0.024). Moderate alcohol consumption (16 to 30 g
per day) also reduced deaths from all causes (RR=
0.36; 95% CI: 0.09 to 0.99; p=0.047). Low (p=0.491)
and high (p=0.204) alcohol intake did not significant-
ly impact on mortality in this population. Subanalyses
using the Cox proportional hazard model and adjusted
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Table 2. Absolute and relative risk of death (unadjusted) from CHD and all causes for given alcohol intakes
Total number Deaths (n) Death rate Risk rate (95% CI) p valuea
of patients (n) (per 1000 person-years) (RR)
Death from CHD:
Daily alcohol intake 0 g/db 153 15 8.8 1
Daily alcohol intake 1-15 g/d 61 5 7.7 0.87 (0.25–2.52) 1.000
Daily alcohol intake 16–30 g/d 42 0 0 0.00 (0.00–0.92) 0.037
Daily alcohol intake >30 g/d 31 1 3.3 0.37 (0.01–2.42) 0.555
Death from all causes:
Daily alcohol intake 0 g/d 153 37 21.8 1
Daily alcohol intake 1-15 g/d 61 18 27.6 1.27 (0.68–2.28) 0.491
Daily alcohol intake 16–30 g/d 42 4 7.7 0.36 (0.09–0.99) 0.047
Daily alcohol intake >30 g/d 31 11 36.2 1.66 (0.77–3.33) 0.204
a Fisher’s exact test (PEPI 4.0)
b g/d: gram per day
Table 3. Results of the Cox proportional hazards regression modela for patients with an alcohol intake of 0 to 30 g per day
Death from all causes (patients drinking 0 to 30 g of alcohol per day)
HRb (95% CI) p value
All patients (256) 0.97 (0.94–1.01) 0.176
Women (123) 0.98 (0.91–1.06) 0.598
Men (133) 0.95 (0.91–0.99) 0.023
a Multivariate model adjusted for age, duration of diabetes, BMI, cholesterol, systolic blood pressure and nicotine consumption
b HR: Hazard ratio
Fig. 1. Kaplan-Meier cumulative function of survival (total
mortality) by different degrees of daily alcohol consumption.
The thick line denotes patients with an alcohol intake of 0 g
per day. Other alcohol-intake groups are as indicated (1 to 
15 g, 16 to 30 g and more than 30 g per day). Grams per day
are denoted in the figure by g/d.
for age, duration of diabetes, BMI, cholesterol level,
systolic blood pressure and smoking (Tables 2 and 3)
indicated a significant reduction (p=0.023) in relative
risk of all-cause mortality in men with light to moderate
alcohol consumption (0 to 30 g per day). No such effect
of alcohol consumption on mortality was shown in
women (p=0.598). Similar analyses on the risk of death
from CHD are not included, as they would be based
primarily on only five events in people with light or
moderate alcohol consumption (1 to 30 g per day).
Discussion
Prospective epidemiological studies have shown that
moderate alcohol consumption noticeably reduces the
risk of cardiovascular morbidity and mortality [3, 4, 16,
17, 18, 19, 20, 21, 22, 23, 24, 25, 26]. These studies pri-
marily targeted healthy adults and showed that moder-
ate alcohol consumption led to a 20 to 60% reduction
of cardiovascular mortality. Recent data obtained in
North American populations also suggest that moderate
alcohol consumption has a beneficial effect on cardio-
vascular morbidity [27] and mortality [7, 8, 9, 10] in
patients with Type 2 diabetes. However, the two recent-
ly published reports had a shorter follow-up than our
study and included health professionals, who are in
many respects specific study populations [8, 10]. One
study had a comparable mixed population and similar
follow-up to ours [7], but it investigated people with a
mean age of 68 years, a large proportion (50%) of
whom were being treated with insulin. In contrast, our
study had younger patients (mean age 46 years), and
fewer patients dependent on insulin. This could partly
explain why CHD-related deaths occurred in only about
10% of our study population, compared to 20% in the
study referred to [7]. Moreover, 53% of people in our
study did not drink, whereas 10% were ranked as heavy
drinkers (more than 30 g alcohol per day). In the US
study [7] only 43% were non-drinkers and less than 4%
were heavy drinkers. Despite these differences, the rela-
tive risk of death from CHD was reduced to a similar
extent in diabetic patients in Europe and the United
States [7] with moderate alcohol consumption, indicat-
ing that ethnicity, drinking pattern and type of alcoholic
beverage have little effect on the protective effects of
alcohol consumption. Similar findings on selected pop-
ulations (US male physicians and US female nurses [8,
10]) and a recent study on drinking pattern and type of
beverages [11] support this hypothesis.
When adjusted for other cardiovascular risk factors,
the cardioprotective effect of moderate alcohol con-
sumption remained in Type 2 diabetic men. In the
Type 2 diabetic women of our cohort no significant
cardioprotective effect could be shown. This contrasts
to previous findings in a healthy population [4] and in
diabetic women [8]. The most likely reason for this
discrepancy is that the majority of women in our study
were non-drinkers (79.2%) or consumed a maximum
of 15 g alcohol per day (12%). Only 8.8% of the dia-
betic women consumed 16 g or more alcohol per day.
The limited number of patients included in the study
and the moderate alcohol consumption by a small
number of women did not allow us to detect an effect
on mortality in women.
In contrast to previous reports, our study also inves-
tigated the relative risk of all-cause mortality in 
association with alcohol consumption, providing evi-
dence that moderate alcohol consumption has a benefi-
cial effect on CHD mortality, while also reducing all-
cause mortality. Our data do not explain these findings.
They do, however, indicate that moderate alcohol in-
take (16 to 30 g per day) was beneficial with regard to
mortality from CHD and from all causes, whereas low-
er and higher alcohol consumption were associated
with a tendency towards a higher mortality risk. This
suggests that the relationship between alcohol con-
sumption and mortality is depicted by a U-shaped
curve, which is consistent with several epidemiological
studies on the relationship between alcohol consump-
tion and all-cause mortality [2, 5] or cardiovascular dis-
ease [28, 29]. The underlying mechanisms for this U-
shaped curve are ill defined. However, most of the stud-
ies claim that the descending limb of the curve is attrib-
utable to reduced death from cardiovascular disease
[28, 30]. High alcohol consumption facilitates the pro-
gression of neuropathy [31] and suppresses hepatic glu-
coneogenesis, thus increasing the risk of hypoglycae-
mia [32]. It is not clear whether these factors contribute
to the greater mortality observed with high alcohol con-
sumption or whether other confounding factors, e.g.
life-style associated with high alcohol intake, contribute
to the present and previous findings.
The power of our study lies in its well-defined co-
hort of European Type 2 diabetic patients (the Swiss
cohort of a multinational WHO study), the long fol-
low-up period and small dropout rate. We cannot ex-
clude the possibility that our small sample size failed
to allow detection of subtle differences in mortality
rates, particularly in women. Moreover, it cannot be
ruled out that the group with light to moderate alcohol
intake contained especially healthy patients, with mod-
erate alcohol consumption simply a marker of overall
healthy behaviour, as suggested previously [10].
In summary, this study confirms that moderate 
alcohol consumption reduces CHD mortality as well 
as all-cause mortality in a relatively young, well-
defined European diabetic cohort. Although the associ-
ations observed do not prove a causal relationship, our
findings indicate that moderate intake of alcohol can be
tolerated in the diet of patients with diabetes mellitus.
However, in light of major clinical and public health
problems associated with heavy drinking, recommenda-
tions on alcohol consumption must be made on an indi-
vidual basis, after carefully assessing the risks and ben-
efits of changes in drinking behaviour.
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